Oncology

Active follow-up after chemoradiotherapy for thoracic esophageal cancer: a comparative analysis of patients with clinical complete response (cCR) managed without surgery and patients with pathological complete response (pCR) after esophagectomy

P. 458-464

Authors: E.A. Toneev N.V. Dengina O.V. Pikin A.E. Slugin M.S. Rudenko N.M. Kiselev S.V. Gamayunov G.G. Torgomyan A.M. Abdrakhmanova

0

438

Anthracycline-free platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: efficacy, safety, and clinicopathological predictors of response

P. 465-473

Authors: E.I. Ratova L.V. Bolotina A.D. Kaprin

0

362

Multicentric and multifocal lobular breast cancer: selection of radical surgical treatment

P. 474-479

Authors: A.A. Tatarova K.S. Titov I.N. Lebedinsky N.Yu. Sokolov S.S. Lebedev D.A. Karseladze

0

565

Determination of a mutational status of the BRAF gene in patients with metastatic colorectal cancer in routine

P. 480-488

Authors: I.D. Trotsenko I.I. Andreyashkina I.E. Khatkov

0

1510

Clinical and laboratory characteristics of the novel coronavirus infection COVID-19 in patients with concomitant oncological pathology

P. 489-494

Authors: I.D. Kanner Zh.B. Ponezheva D.V. Usenko

0

345

Genetic medicine in cancer treatment: CAR T-сell therapy (a literature review)

P. 495-499

Authors: K.A. Aitbaev I.T. Murkamilov V.V. Fomin F.A. Yusupov A.F. Yusupov T.F. Yusupova

0

378

Modern systemic therapy for patients with BRAF-mutant melanoma and brain metastases: a scoping review

P. 500-508

Authors: A.V. Novik

0

412

Encorafenib and binimetinib in the treatment of metastatic melanoma

P. 509-524

Authors: I.V. Rykov A.R. Alekseeva E.K. Alieva V.I. Evdokimov T.N. Kochneva E.S. Kuzmina I.V. Myslevtsev V.S. Myagkova E.V. Lymar P.V. Koposov A.A. Kurmanaliev K.V. Orlova I.A. Sosnina A.V. Stupina V.A. Chubenko P.V. Eskina Yu.V. Puras

0

500